Share on StockTwits

Amgen (NASDAQ:AMGN)’s share price hit a new 52-week high during mid-day trading on Monday , Stock Ratings Network.com reports. The stock traded as high as $134.93 and last traded at $134.13, with a volume of 1,264,011 shares changing hands. The stock had previously closed at $132.82.

Several analysts have recently commented on the stock. Analysts at Argus reiterated a “buy” rating on shares of Amgen in a research note on Monday, August 4th. They now have a $140.00 price target on the stock, up previously from $135.00. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Amgen in a research note on Thursday, July 31st. They now have a $137.00 price target on the stock. Finally, analysts at Leerink Swann raised their price target on shares of Amgen from $135.00 to $140.00 in a research note on Thursday, July 31st. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. Amgen presently has an average rating of “Buy” and an average price target of $140.00.

The stock’s 50-day moving average is $124.8 and its 200-day moving average is $120.1. The company has a market cap of $102.4 billion and a P/E ratio of 20.34.

Amgen (NASDAQ:AMGN) last released its earnings data on Tuesday, July 29th. The company reported $2.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.07 by $0.30. The company had revenue of $5.18 billion for the quarter, compared to the consensus estimate of $4.90 billion. During the same quarter in the previous year, the company posted $1.89 earnings per share. The company’s revenue for the quarter was up 10.7% on a year-over-year basis. Analysts expect that Amgen will post $8.40 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Friday, September 5th. Stockholders of record on Thursday, August 14th will be paid a dividend of $0.61 per share. This represents a $2.44 annualized dividend and a dividend yield of 1.84%. The ex-dividend date is Tuesday, August 12th.

Amgen Inc is a global biotechnology pioneer that discovers, develops, manufactures and delivers human therapeutics.

Receive News & Ratings for Amgen Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amgen Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.